Results 181 to 190 of about 12,417 (199)

Effects of alteplase beyond 3 h after stroke in the Echoplanar Imaging Thrombolytic Evaluation Trial (EPITHET): a placebo-controlled randomised trial

Lancet Neurology, The, 2008
Stephen M Davis, Mark W Parsons, Christopher Levi   +2 more
exaly  

Endovascular Thrombectomy with or without Intravenous Alteplase in Acute Stroke

New England Journal of Medicine, 2020
Pengfei Yang, Yongwei Zhang, Lei Zhang
exaly  

Tenecteplase versus alteplase for management of acute ischaemic stroke (NOR-TEST): a phase 3, randomised, open-label, blinded endpoint trial

Lancet Neurology, The, 2017
Nicola Logallo, Vojtech Novotny, Jörg Aβmus   +2 more
exaly  

Alteplase

Reactions Weekly, 2021
openaire   +1 more source

Thrombolysis with alteplase 3–4·5 h after acute ischaemic stroke (SITS-ISTR): an observational study

Lancet, The, 2008
Niaz Ahmed, Werner Hacke, Keith W Muir
exaly  

Stroke treatment with alteplase given 3·0–4·5 h after onset of acute ischaemic stroke (ECASS III): additional outcomes and subgroup analysis of a randomised controlled trial

Lancet Neurology, The, 2009
Erich Bluhmki, Joanna M Wardlaw, Werner Hacke   +2 more
exaly  

Comparison of intravenous alteplase with a combined intravenous–endovascular approach in patients with stroke and confirmed arterial occlusion (RECANALISE study): a prospective cohort study

Lancet Neurology, The, 2009
Mikael Mazighi, Elena Meseguer, bertrand Lapergue   +2 more
exaly  

Alteplase

Reactions, 1988
openaire   +1 more source

Implementation and outcome of thrombolysis with alteplase 3–4·5 h after an acute stroke: an updated analysis from SITS-ISTR

Lancet Neurology, The, 2010
Niaz Ahmed, Robert Mikulik, Risto O Roine   +2 more
exaly  

Alteplase

Reactions Weekly, 2007
openaire   +1 more source